PHL-FLUCONAZOLE CAPSULE

国家: 加拿大

语言: 英文

来源: Health Canada

现在购买

产品特点 产品特点 (SPC)
01-05-2007

有效成分:

FLUCONAZOLE

可用日期:

PHARMEL INC

ATC代码:

J02AC01

INN(国际名称):

FLUCONAZOLE

剂量:

150MG

药物剂型:

CAPSULE

组成:

FLUCONAZOLE 150MG

给药途径:

ORAL

每包单位数:

1

处方类型:

OTC

治疗领域:

AZOLES

產品總結:

Active ingredient group (AIG) number: 0122529004; AHFS:

授权状态:

CANCELLED POST MARKET

授权日期:

2007-08-01

产品特点

                                PRODUCT MONOGRAPH
PR
PHL-FLUCONAZOLE
(Fluconazole)
C
Tablets 100 mg
C
Capsules 150 mg
ANTIFUNGAL AGENT
PHARMEL INC.
DATE OF PREPARATION:
6111 Royalmount Ave., Suite 100
May 1, 2007
Montreal, Quebec
H4P 2T4
CONTROL NO. 113587
Page 2 of 47
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY
PRODUCT
INFORMATION.................................................................................
3
INDICATIONS
AND
CLINICAL
USE
......................................................................................
3
CONTRAINDICATIONS
...........................................................................................................
4
WARNINGS
AND
PRECAUTIONS
..........................................................................................
4
ADVERSE
REACTIONS............................................................................................................
7
DRUG
INTERACTIONS
..........................................................................................................
12
DOSAGE
AND
ADMINISTRATION
......................................................................................
16
OVERDOSAGE
........................................................................................................................
19
STORAGE
AND
STABILITY
..................................................................................................
21
DOSAGE
FORMS,
COMPOSITION
AND
PACKAGING ...................................................... 21
PART II: SCIENTIFIC INFORMATION
...............................................................................
23
PHARMACEUTICAL
INFORMATION..................................................................................
23
C
LINICAL
T
RIALS
........................................................................................................................
23
DETAILED
PHARMACOLOGY
.............................................................................................
25

                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报